Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors.Scheiper, B., Matter, H., Steinhagen, H., Stilz, U., Bocskei, Z., Fleury, V., McCort, G.
(2010) Bioorg Med Chem Lett 20: 6268-6272
- PubMed: 20850300
- DOI: https://doi.org/10.1016/j.bmcl.2010.08.092
- Primary Citation of Related Structures:
3OOT, 3OQF, 3OQK
- PubMed Abstract:
Selective inhibition of the aspartyl protease renin has gained attraction as an interesting approach to control hypertension and associated cardiovascular risk factors given its unique position in the renin-angiotensin system. Using a combination of high-throughput screening, parallel synthesis, X-ray crystallography and structure-based design, we identified and optimized a novel series of potent and non-chiral indole-3-carboxamides with remarkable potency for renin. The most potent compound 5k displays an IC(50) value of 2nM.
Sanofi-Aventis Deutschland GmbH, Chemical and Analytical Sciences, Building G878, D-65926 Frankfurt, Germany. Bodo.Scheiper@sanofi-aventis.com